Effect of zinc oxide nanoparticles on wound healing

Randomised controlled trial on effect of Zinc Oxide Nanoparticles on chronic wounds - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/09/094750

Enrollment

144

Registered

2025-09-15

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E135- Other specified diabetes mellituswith circulatory complications Health Condition 2: L891- Pressure ulcer of back Health Condition 3: I832- Varicose veins of lower extremities with both ulcer and inflammation

Interventions

Intervention1: Zinc oxide nanoparticles: Application of Zinc oxide nanoparticles in gel form over chronic wounds depending upon the surface area of wound on alternate days upto a maximum of ten weeks

Eligibility

Inclusion criteria

Inclusion criteria: All patients of Chronic wounds (Diabetic foot ulcers, Venous ulcers, Pressure ulcers)

Exclusion criteria

Exclusion criteria: Patient not giving consent Patient already on other modalities of treatment other than simple dressings (NPWT, Bacteriophage therapy, Electrical stimulations, etc.) Radiation therapy Chemotherapy Hemoglobin less than 10 mg per dL Pregnant and Lactating females Patients with lymphedema and lymphangitis

Design outcomes

Primary

Measure	Time frame
To measure the reduction in wound sizeTimepoint: 10 weeks	—

Secondary

Measure	Time frame
To estimate the change in level of collagenTimepoint: 10 weeks	—

Countries

India

Contacts

Public ContactVipul Kumar Srivastava

Institute of Medical Sciences BHU

vipulsrivastava@bhu.ac.in8005100548

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026